APAC to witness fastest growth in remote medical robots | Health Care Asia Magazine

APAC to witness fastest growth in remote medical robots

Supportive government initiatives are expected to propel market growth.

The Asia Pacific is expected to witness the fastest growth for medical telepresence robots from 2021 to 2028 owing to the higher adoption of robotics in the healthcare sector and the supportive government initiatives in medical robotics, a report from Grand View Research revealed.

Globally, the market for medical telepresence robots is expected to reach $159.5m by 2028, at a compound annual growth rate of 18.5% from 2021 to 2028, partly boosted by the growing adoption of telepresence robots in the healthcare sector and product innovations catering to the increasing demand.

Moreover, the rise in the elderly population with chronic illnesses requiring regular monitoring is expected to propel the demand for medical telepresence robots, especially for home use.

In 2020, North America dominated the market due to the higher adoption of artificial intelligence and robotics in the healthcare sector, growing disposable income, and the rising number of market players in the region.

The mobile segment dominated the market in 2020 owing to the features such as autonomous navigation, adjustable height, head motion, and obstacle avoidance that enable smooth and efficient delivery of services and virtual monitoring.

Get Health Care Asia Magazine in your inbox
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

The majority of the country’s pharma manufacturing produces generic drugs.
This is expected to affect local pharma growth in the short term.
Nonetheless, more than half of the age group found its use to be comfortable.
The group’s profits after tax ballooned by as much as 138.4%.
Funds will be used to build out its behavioural health and chronic care modules.
Some players have been highly active in digital channels of various countries.
It has also formed a JV with Acurio to develop a private hospital in NSW.
With this, the company now offers an all-in-one patient management service.
The therapy can be done in eight different languages.
The country is expected to have one in five of its population to be elderly by 2050.
Sunway is planning to ramp up its hospital capacity to about 3,000 beds.
The system will help city managers to track epidemic conditions, real-time.
It is funded through the 2020 Primary Healthcare Research Data Infrastructure grants.
The hospital features 200 general inpatient beds and 100 hemodialysis beds.
The platform expanded its services after obtaining an internet hospital license.